Drug recall · December 11, 2013
Morphine Sulfate Injection recall
Why: Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.
- Lots / codes
Lot #17368EV Exp 08/13
- Quantity
- 29,700 vials
- Company
- Hospira, Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- September 16, 2013 · Voluntary: Firm initiated
- Classified
- December 2, 2013
- Reported
- December 11, 2013
- Ended
- October 28, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.